Skip to main content

Table 3 Observed scores for Cohort B (2018–2020) and Cohort A (2008–2009) groups of young people in residential substance use disorder treatment receiving dialectical behaviour therapy: Psychiatric symptoms, substance use, and quality of life outcomes

From: Now and then: a ten-year comparison of young people in residential substance use disorder treatment receiving group dialectical behaviour therapy

Outcome

Cohort B

Cohort A

n

M (SD)

n

M (SD)

Psychiatric symptoms

 BSI

  Baseline

78

67.9 (11.9)

102

63.7 (11.7)

  6-weeks (mid-treatment)

40

67.4 (10.1)

62

55.2 (14.0)

  12-weeks (end-of-treatment)

28

62.6 (12.4)

21

50.9 (13.5)

  6-months

27

67.8 (11.9)

  

  12-months

24

68.6 (11.5)

  

Substance use

 BSCQ

  Baseline

77

45.0 (24.8)

102

45.8 (23.5)

  6-weeks (mid-treatment)

40

67.0 (22.7)

63

67.3 (20.2)

  12-weeks (end-of-treatment)

28

65.0 (29.5)

7

74.4 (22.3)

  6-months

27

50.1 (28.6)

  

  12-months

24

54.3 (31.6)

  

 SDS

  Baseline

76

9.5 (3.0)

  

  6-weeks (mid-treatment)

40

7.7 (3.3)

  

  12-weeks (end-of-treatment)

28

8.6 (4.0)

  

  6-months

27

5.0 (3.5)

  

  12-months

24

5.7 (5.0)

  

Quality of life

 QOL

  Baseline

79

3.2 (0.8)

  

  6-weeks (mid-treatment)

40

3.6 (0.6)

  

  12-weeks (end-of-treatment)

26

3.7 (0.7)

  

  6-months

27

3.2 (0.7)

  

  12-months

24

3.4 (0.7)

  
  1. BSCQ Brief Situational Confidence Questionnaire, BSI Brief Symptom Inventory Global Severity Index, SDS Severity of Dependence Scale, QOL World Health Organisation Quality of Life-8